PRESENTING
SPONSOR
Panasonic Logo
IN ASSOCIATION
WITH
TECHNOLOGY
PARTNER
IN ASSOCIATION
WITH
Wednesday, April 1, 2015| Latest E-book
You are here:
Drugmakers
#

Drugmakers

Articles

View all

US drugmaker Merck grants free license for pediatric HIV drug

Feb 24, 2015

US drugmaker Merck grants free license for pediatric HIV drug

Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus. #US #NewsTracker #HIV #Drugs #drugmaker #Merck #pediatric
India battles HIV/AIDS drug shortage as some firms halt supply

Sep 04, 2014

India battles HIV/AIDS drug shortage as some firms halt supply

India is facing a shortage of HIV/AIDS drugs provided under government's free medicine programme after drugmakers halted supplies due to delayed payment #NewsTracker #HIV #AIDS #HIV drugs #Indian drugmakers #NACO #shortage of medicine
Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers